Segall Bryant & Hamill’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.14M Sell
22,499
-399
-2% -$48.9K 0.03% 416
2025
Q4
$3.77M Sell
22,898
-276
-1% -$36.6K 0.05% 347
2025
Q3
$2.39M Buy
+23,174
New +$2.27M 0.03% 405

Other funds holding NUTX

Segall Bryant & Hamill's NUTX Position: Q1 2026 in Review

Segall Bryant & Hamill reduced its Nutex Health (NUTX) stake by 1.7% in Q1 2026, selling an estimated $48.9K and leaving 22,499 shares worth $2.14M. The position accounts for 0.03% of the portfolio, ranked #416.

Segall Bryant & Hamill first reported a position in NUTX in Q3 2025 and has held it in 3 quarters since. The position peaked at $3.77M in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • Segall Bryant & Hamill held 22,499 shares of Nutex Health worth $2.14M as of Q1 2026.
  • Segall Bryant & Hamill sold 399 Nutex Health shares in Q1 2026, an estimated $48.9K.
  • Nutex Health made up 0.03% of Segall Bryant & Hamill's portfolio in Q1 2026, its #416 holding.
  • Segall Bryant & Hamill first reported a position in Nutex Health in Q3 2025 and has held it in 3 quarters since.
  • Segall Bryant & Hamill's Nutex Health position peaked at $3.77M in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on Segall Bryant & Hamill's 13F filing for Q1 2026, filed 15 May 2026.